Research Article
Value of Assessing Autonomic Nervous Function by Heart Rate Variability and Heart Rate Turbulence in Hypertensive Patients
Table 1
Clinical characteristic of N-HP group and HP group.
| | | N-HP group | HP group | P value | | (n=80) | (n=120) |
| | Age (yr) | 56.66±6.62 | 58.05±7.55 | 0.183 | | Male gender (n, %) | 39/80 (48.5%) | 54/120 (45.0%) | 0.602 | | BMI (kg/m2) | 23.60±2.78 | 25.20±3.29 | <0.0001 | | Smoker (n, %) | 21/80 (26.3%) | 40/120 (33.3%) | 0.286 | | Stable CAD (n, %) | 12/80 (15.0%) | 37/120 (30.8%) | 0.011 | | Dyslipidemia (n, %) | 64/80 (80.0%) | 105/120 (87.5%) | 0.151 | | Systolic blood pressure (mmHg) | 118.50±11.75 | 134.98±14.95 | <0.0001 | | Diastolic blood pressure (mmHg) | 76.10±7.48 | 81.98±10.15 | <0.0001 | | Heart rate (bpm) | 74.18±6.62 | 73.11±8.16 | 0.307 | | Creatinine (μM) | 67.44±16.33 | 67.34±14.63 | 0.839 | | CHOL (mM) | 4.67±0.91 | 4.83±1.00 | 0.228 | | TG (mM) | 1.59±0.98 | 2.13±2.10 | 0.002 | | LDL-c (mM) | 2.96±0.83 | 2.92±0.82 | 0.742 | | HDL-c (mM) | 1.09±0.25 | 1.10±0.27 | 0.848 | | Ejection fraction (%) | 61.61±4.95 | 61.91±5.17 | 0.657 | | LVEDd (cm) | 4.39±0.39 | 4.40±0.44 | 0.843 | | IVS (cm) | 0.93±0.12 | 0.99±0.19 | 0.010 | | Medication | | | | | Bata-blockers use (n, %) | 23/80 (28.8%) | 60/120 (50.0%) | 0.003 | | Diuretics use (n, %) | 0/80 (0.0%) | 12/120 (10.0%) | 0.009 |
|
|
N-HP, nonhypertensive; HP, hypertensive; BMI, body mass index; CAD, coronary artery disease; CHOL, cholesterol; TG, triglyceride; LDL-c, low-density lipoprotein cholesterol; HDL-c, high-density lipoprotein cholesterol; LVEDd, left ventricular end diastolic diameter; IVS, interventricular septum.
|
